COVID-19 has Stimulated the CPAP Market
Worldwide markets are poised to achieve continuing growth as CPAP proves value by providing airway support during sleep to a larger percent of the worldwide population.
The research report is an analysis of the factors that augment the CPAP market growth including taking devices off prescription. It documents market trends, restraints, and opportunities. It describes market drivers that promise to transform sleep management. Factors impacting the market in either a positive or negative manner are described. The scope of different segments and the variety of applications that can potentially influence the market are identified and discussed. Detailed information is based on current trends and historic milestones.
The CPAP study provides a compelling case for putting devices off prescription. Despite devices being on the market since 1980, less than 20% of the people who need them have a CPAP device. The pressure delivered air during sleep is able to mitigate the onset of high blood pressure, cardiac arrhythmia, and type 2 diabetes. These chronic diseases represent a significant part of the cost of healthcare delivery. To be able to mitigate the onset of the severity of the chronic disease is of interest to every healthcare provider.
A strong association has been discovered between sleep apnea and a number of cardiovascular and metabolic diseases. Studies have shown that sleep apnea is present in approximately 83% of patients with drug-resistant hypertension. While sleep apnea has been diagnosed in a broad cross-section of the population, until recently, it has typically been used to treat middle-aged, middle and upper-class white men who are obese. The importance of sleep apnea in people is increasingly being recognized. 40% of new PAP patients are female.
Taking CPAP devices off prescription would move the current recommender base to vendors. Putting the onus of education on CPAP vendors who typically have very large marketing budgets and access to TV and other advertising venues is likely to be a positive move in the industry.
It is estimated that less than 20% of those with OSA have been diagnosed or treated. This data provides compelling reasons to take CPAP devices off prescription. Many healthcare professionals are often unable to diagnose OSA because they are unaware that non-specific symptoms as excessive daytime sleepiness, snoring, hypertension and irritability are characteristic of OSA.
Covid-19 restrictions-imposed restrictions on the activities of corporations and people. The restrictions have resulted in the increased use of CPAP. Covid spread has created a demand for oxygen delivery, one that is facilitated by CPAP. Pandemic response demands that people have access to good breathing assist devices. CPAP fills this need.
Demand for CPAP began to rapidly increase with Covid-19. According to the lead author of the study on the CPAP market, “During the current pandemic, CPAP has become a go to means of supporting respiration.”
The growth in CPAP markets is anticipated to last for five years and perhaps beyond as a larger portion of the people who need respiratory support during sleep get it.
Key Topics Covered:
- Off Prescription Extends Market Opportunity by 800%
- Impact of Philips Recall and Covid-19 and the CPAP Market
- Current demand - Timeline of recovery
- Industry disruptions
- Short-term and long-term industry changes
- Consumer behavior changes, to what degree shifts likely become permanent
- Supply chains operations - Building a more stable and resilient supply chain
- Growth market segments
- Pockets of growth during COVID-19 and beyond
- Marketing in this new industry climate
- Exposures - Risks
- CPAP
- BiPAP
- APAP
- PVA
- Pressure Variation Algorithm
- CPAP Recall Devices
- Sleep Style
- Auto CPAP
- Automated Data Transfer
- Connected Care
- Sleep and Respiratory Medical Technologies
- OSA Mask
- Sleep Fragmentation
- CPAP Strategic Planning Factors
- Causes of Sleep Apnea
- Sleep Apnea
- COVID-19
- Marketing CPAP
- Forecasts & Market Shares
Table of Contents
1. CPAP: Market Description and Market Dynamics
1.1 What Causes Sleep Apnea?
2. CPAP Market Shares and Forecasts
2.1 CPAP Market Driving Forces
2.1.1 Covid19 Pandemic CPAP Market Impact
2.2 CPAP Market Shares
2.2.1 CPAP/BiPAP/APAP Market Unit Analysis
2.3 CPAP/BiPAP/APAP Forecasts
2.3.1 CPAP/BiPAP/APAP Unit Analysis
2.3.2 CPAP /BiPAP/APAP Installed Units
2.4 CPAP/BiPAP/APAP Market Segment Forecasts
2.4.1 CPAP
2.4.2 BiPAP
2.4.3 APAP
2.4.4 Strategic Planning Factors
2.5 CPAP Prices
2.5.1 ResMed AirSense 10, Price $833
2.5.2 Philips Respironics DreamStation
2.5.3 Fisher & Paykel SleepStyle Auto CPAP
2.5.4 China CPAP
2.6 CPAP Regional Analysis
3. Philips' CPAP Recall and CPAP Positioning: Market Opportunity
3.1 Philips' CPAP Recall Notification 2021
3.2 Polyester-Based Polyurethane (PE-PUR) Sound Abatement Foam Could Cause Harmful Side Effects
3.2.1 Philips' CPAP Recall Devices Impacted
3.3 Philips CPAP Recall
3.3.1 Philips' CPAP Recall Notification 2021 and Solutions
3.4 Legal Protection from Dangerous Medical Devices
3.5 Sleep Fragmentation
3.6 Automatic Positive Airway Pressure Monitoring Devices
3.7 Obesity Hypoventilation Syndrome
3.8 Neuromuscular Disease
3.9 CPAP Market Extended by Home Monitoring and Automated Settings
3.10 Sleep
4. CPAP Healthcare Coverage and Technology
4.1 26% Of Adults Age 30-70 Have Some Form of Obstructive Sleep Apnea
4.2 Common Type of OSA Mask
5. CPAP Company Profiles
5.1 3B Medical
5.2 Apex
5.2.1 Apex PVA Pressure Variation Algorithm
5.2.2 Apex Enhanced Pressure Stability
5.2.3 Apex Medical Revenue
5.3 BMC Medical
5.4 Fosun Pharma/Breas
5.4.1 Fosun Pharma 2020 Revenue
5.4.2 Breas
5.5 Medical Depot/Drive Medical/DeVilbiss
5.5.1 Drive Medical/DeVilbiss CPAP
5.5.2 Drive DeVilbiss Healthcare Response to Philips CPAP Recall
5.5.3 Drive Medical Revenue
5.6 Fisher & Paykel
5.6.1 Fisher & Paykel SleepStyle Auto CPAP Fisher Paykel Modem - Automated Data Transfer Via Internet and Cellular Network
5.7 Philips
5.7.1 Respironics DreamStation Auto Quiet CPAP
5.7.2 Philips Healthcare Revenue
5.7.3 Philips Connected Care Businesses
5.8 ResMed
5.8.1 ResMed AirMini Travel CPAP
5.8.2 ResMed AirSense 10 CPAP
5.8.3 ResMed AirSense 10 AutoSet CPAP
5.8.4 ResMed Sleep and Respiratory Care Revenue
5.9 Signifier Medical Technologies
5.10 Smiths Group
5.11 T A Associates
5.12 Teijin Pharma Limited
5.11 Selected List of CPAP Companies
List of Figures
Figure 1. CPAP/BiPAP/APAP Regional Market Segments, Dollars, 2020
Figure 2. CPAP/BiPAP/APAP Regional Market Segments, Dollars, 2020
Figure 3. Common Risk Factors for Sleep Apnea
Figure 4. CPAP Parts and Functions
Figure 5. CPAP Machine User Problems
Figure 6. Mayo Clinic Common CPAP Problems and Solutions
Figure 7. CPAP/BiPAP/APAP Market Shares, Dollars, 2020
Figure 8. CPAP/BiPAP/APAP Market Shares, Combined Total, Dollars, Worldwide, 2020
Figure 9. CPAP/BiPAP/APAP Market Shares, in Dollars, Worldwide, 2020
Figure 10. CPAP/BiPAP/APAP Market Shares, in Percent, Dollars, Worldwide, 2020
Figure 11. CPAP/BiPAP/APAP Market Shares, Units, Worldwide, 2020
Figure 12. CPAP/BiPAP/APAP Market Shares, Percent, Units, Worldwide, 2020
Figure 13. CPAP/BiPAP/APAP Market Shares, $ per Unit, Unit Analysis, Worldwide, 2020
Figure 14. CPAP/BiPAP/APAP Forecasts Dollars, Worldwide, 2021-2027
Figure 15. CPAP/BiPAP/APAP Forecasts Dollars, Worldwide, 2021-2027
Figure 16. Respiratory Care Key Market Growth Elements
Figure 17. CPAP /BiPAP APAP Installed Units, Worldwide, 2021-2027
Figure 18. CPAP Fundamentals
Figure 19. CPAP Market Forecasts, Dollars, Worldwide, 2021-2027
Figure 20. BiPAP Market Forecasts, Dollars, Worldwide, 2021-2027
Figure 21. APAP Market Forecasts, Dollars, Worldwide, 2021-2027
Figure 22. CPAP/BiPAP/APAP Market Segments, Dollars, Percent of Total, Worldwide, 2021
Figure 23. CPAP/BiPAP/APAP Market Segments, Dollars, Percent of Total, Worldwide, 2027
Figure 24. CPAP/BiPAP/APAP Market Segments, Dollars and Percent of Total, Worldwide, 2021-2027
Figure 25. Fisher & Paykel SleepStyle Auto CPAP Machine
Figure 26. CPAP 100 Loud Devices
Figure 27. CPAP/BiPAP/APAP Regional Market Segments, Dollars, 2020
Figure 28. CPAP/BiPAP/APAP Regional Market Segments, Dollars, 2020
Figure 29. CPAP/BiPAP/APAP Regional Market Segments, Dollars, 2020
Figure 30. FDA Philips Respironics CPAP and Ventilator Models Recalled
Figure 31. Philips DreamStation Recalled
Figure 32. Philips DreamStation ASV Recalled
Figure 33. Philips DreamStation ST, AVAPS Recalled
Figure 34. Philips DreamStation CPAP, Auto CPAP, BiPAP and other Devices Recalled
Figure 35. CPAP Nighttime Mask
Figure 36. 3B Medical CPAP
Figure 37. 3B Medical CPAP Features
Figure 38. Multi-Stage Noise Reduction Technology
Figure 39. Apex CPAP
Figure 40. Apex Enhanced Pressure Stability Functions
Figure 41. BMC CPAP/APAP Products
Figure 42. Drive Medical/DeVilbiss CPAP
Figure 43. Drive Medical CPAP Features
Figure 44. Fisher & Paykel SleepStyle Auto CPAP Machine
Figure 45. Filtration Efficiencies of F&P Filters
Figure 46. Fisher & Paykel Revenue
Figure 47. Respironics DreamStation Functions and Difficulties
Figure 48. Philips Respironics Dream Station CPAP
Figure 49. Philips Group Revenue 2020
Figure 50. ResMed AirMini Travel CPAP Features
Figure 51. ResMed AirSense 10 AutoSet CPAP
Figure 52. ResMed AirSense 10 AutoSet
Figure 53. ResMed CPAP Functions
Figure 54. ResMed CPAP Products
Figure 55. ResMed Revenue 2020
Figure 56. ResMed Regional Revenue Segments
Figure 57. ResMed Sleep and Respiratory Care Revenue
Figure 58. Signifier Medical Technologies (SMT) Daytime Device that Strengthens the Throat
Figure 59. Smiths Group Financial Performance F/I 2020
Figure 60. Smiths Group Regional Financial Performance F/I 2020
Figure 61. Smiths Group Revenue F/I 2020
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3B Medical
- Apex
- BMC Medical
- Breas
- DeVilbiss
- Drive Medical
- Fisher & Paykel
- Fosun Pharma
- Medical Depot
- Philips
- ResMed
- Signifier Medical Technologies
- Smiths Group
- T A Associates
- Teijin Pharma Limited
Methodology
LOADING...
